Claro Banner 1 - edit

Bioprintable gels for extrusion-based bioprinting

Claro is a leading developer of Bioprintable Gels featuring tailored behaviour for extrusion-based bioprinting. 

BG800

1F6A2528_1.jpg

BG800 is a freeze-dried gelatin-based bio-ink modified with methacryloyl groups (GelMA) exhibiting rheological properties tailored for extrusion-based bioprinting. BG800 overcomes clogging and the poor shape-fidelity observed with regular GelMA products without affecting the intrinsic biocompatibility of gelatin and the gel strength of the matrix. BG800 is crosslinkable under UV or visible light, depending on the photo-initiator used in the formulation.

BG800 is produced under high-quality standards of purification, ensuring ultra-low levels of impurities such as methacrylic acid and guaranteeing batch-to-batch consistency.

BG800 is available in:

  • 3 x 500 mg containers
  • 6 x 500 mg containers
  • 12 x 500 mg containers

For research use only. Not for human use.

BG800 Hydrogel

1F6A2572_1.jpg

Bioprinting with GelMA has never been easier! BG800 combines all the benefits of Claro technology with a time-efficient bio-ink formulation. You can skip the dissolution of freeze-dried GelMA. BG800 hydrogel (20% w/v) matrix can be easily mixed with cell suspensions and a photoinitiator solution.

BG800 hydrogel is available in syringes:

  • 2 x 5 ml
  • 5 x 5 ml
  • 10 x 5 ml

For research use only. Not for human use.

3D BIOprint GelMA with tried and tested printing parameters so you can focus on your findings, backed by the intelligent synergy of machine and medium.

Claro BG product line was designed to empowering the flow during bioprinting. Our BG800  maintains its smooth printing flow without clogging and retains its printed shape thanks to just the right amount of elasticity, as is visible in this 3D printed honeycomb structure.

Together, ClaroTM and FELIX BIOprinters ensure successful bioprinting with GelMA so you can reach all your research goals.

Empower the flow of your research

Contact our team